Routine share dematerialization certificate filed for Q2 FY27

Omkar Pharmachem's registrar Alankit Assignments has submitted the routine quarterly certificate under SEBI regulation 74(5) for the quarter ended September 30, 2026. The certificate confirms that shares received for dematerialization were processed and listed on the exchange, and that physical certificates were mutilated and cancelled, with the depository's name substituted in the company's register of members. This is a standard procedural filing with no operational or financial impact.